Market By Application, Route Of Administration, End-user And Country | Forecast 2019-2028
Triton Market Research, in its report, has determined that the clinical nutrition market in the Middle East and Africa is anticipated to progress at a CAGR of 3.73% in the projected period (2019-2028).
Report scope can be customized per your requirements. Request For Customization
The countries studied in the Middle East and Africa market are:
• Saudi Arabia
• Turkey
• United Arab Emirates
• South Africa
• Rest of Middle East & Africa
In the Middle East, there has been a significant change in the healthcare patterns related to nutrition over the last two decades. The changes in the demographic characteristics, rapid urbanization, and social development are the primary factors contributing to these changes. This is likely to benefit the growth of the clinical nutrition market in the region.
Saudi Arabia has been witnessing an increased prevalence of nutrition-related diseases and other health problems. This has fueled the demand for clinical nutrition in the country. Various illnesses are linked to nutrition, by generally being a part of the treatment. Diet-related ailments are on an upsurge due to the increasingly unhealthy diet and lifestyle. Cardiovascular diseases and diabetes have become the leading cause of deaths in Saudi Arabia.
The prevalence of diabetes has approximately registered a significant increase in the last three decades. It is reported that nutrition-focused educational services have a positive impact on public health. Nutritional counseling is likely to make a positive impact on glycemic control in diabetic patients. Hence, the country is one of the most promising markets for clinical nutrition in the Middle East. This is likely to aid the studied market growth over the upcoming years.
Established in 1823, Reckitt Benckiser Group Plc is a company involved in the manufacturing and marketing of hygiene, health, post-natal and home products. It has a wide portfolio of brands including Durex, Dettol, Scholl, Mucinex, Strepsils, Lysol, Mortein, Veet, Clearasil and Harpic. It has operations in different regions, including the Middle East and Africa. Nutramigen is a supplement provided by the company used for the dietary management of CMA (cow’s milk allergy) in infants.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. KEY INSIGHTS
2.7. MARKET DRIVERS
2.7.1. INCREASING NUMBER OF PEOPLE SUFFERING FROM CHRONIC HEALTH DISEASES
2.7.2. SURGING NUMBER OF MALNUTRITION VICTIMS
2.8. MARKET RESTRAINTS
2.8.1. DIFFICULTIES RELATED TO ENTERAL FEEDING
2.8.2. LACK OF AWARENESS REGARDING CLINICAL NUTRITION
2.9. MARKET OPPORTUNITIES
2.9.1. GROWING AGING POPULATION
2.9.2. RISING USAGE OF CLINICAL NUTRITION IN DEVELOPING COUNTRIES
2.10. MARKET CHALLENGES
2.10.1. STRINGENT REGULATORY FRAMEWORK
2.10.2. FALSE PERCEPTIONS ASSOCIATED WITH MALNUTRITION
3. CLINICAL NUTRITION MARKET OUTLOOK - BY APPLICATION
3.1. CANCER
3.2. NEUROLOGICAL DISEASES
3.3. GASTROINTESTINAL DISORDERS
3.4. METABOLIC DISORDERS
3.5. OTHER APPLICATIONS
4. CLINICAL NUTRITION MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. ENTERAL
4.3. PARENTERAL
5. CLINICAL NUTRITION MARKET OUTLOOK - BY END-USER
5.1. PEDIATRIC
5.2. GERIATRIC
5.3. ADULTS
6. CLINICAL NUTRITION MARKET – MIDDLE EAST AND AFRICA
6.1. SAUDI ARABIA
6.2. TURKEY
6.3. UNITED ARAB EMIRATES
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPANY PROFILES
7.1. NESTLE HEALTH SCIENCE
7.2. BASF SE
7.3. AVADEL PHARMACEUTICALS
7.4. MEIJI HOLDINGS CO LTD
7.5. BAXTER INTERNATIONAL INC
7.6. RECKITT BENCKISER GROUP PLC
7.7. B BRAUN
7.8. SANOFI SA
7.9. AMERICAN REGENT INC
7.10. OTSUKA HOLDINGS CO LTD
7.11. ABBOTT LABORATORIES
7.12. SICHUAN KELUN PHARMACEUTICAL CO LTD
7.13. LONZA INC
7.14. DANONE
7.15. GRIFOLS SA
7.16. EXELA PHARMA SCIENCES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 DIFFICULTIES ASSOCIATED WITH ENTERAL FEEDING
FIGURE 3 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
FIGURE 14 SAUDI ARABIA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 15 TURKEY CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 16 UNITED ARAB EMIRATES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 17 SOUTH AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 18 REST OF MIDDLE EAST & AFRICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)